According to Fixygen, PJSC “Pharmaceutical Company “Darnitsa” will hold its annual shareholders’ meeting on April 24, 2026, in Kyiv. In the published notice, the company listed 12 agenda items, including the CEO’s report for 2025, the supervisory board’s report, approval of financial and operational results and annual information, review of the audit report, profit distribution, preliminary approval of significant transactions for 2026–2027, amendments to the charter, as well as the termination of powers and re-election of the supervisory board and approval of contract terms with its members.
Darnitsa is one of Ukraine’s largest pharmaceutical companies and one of the country’s best-known manufacturers of medicines.
The company was founded in 1930 and produces a wide range of prescription and over-the-counter drugs.
Its production facilities and headquarters are located in Kyiv. The company remains a privately held Ukrainian pharmaceutical group with a strong position in the domestic market.
https://www.fixygen.ua/news/20260331/darnitsya-provede-zbori-aktsioneriv-24-kvitnya.html
